Brokerages Anticipate Monsanto Company (MON) Will Post Earnings of -$0.38 Per Share

Wall Street analysts expect Monsanto Company (NYSE:MON) to announce earnings of ($0.38) per share for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Monsanto’s earnings. The highest EPS estimate is ($0.22) and the lowest is ($0.47). Monsanto posted earnings of $0.07 per share during the same quarter last year, which suggests a negative year-over-year growth rate of 642.9%. The business is expected to announce its next earnings report before the market opens on Wednesday, October 4th.

According to Zacks, analysts expect that Monsanto will report full year earnings of $4.96 per share for the current fiscal year, with EPS estimates ranging from $4.85 to $5.10. For the next fiscal year, analysts expect that the firm will post earnings of $5.42 per share, with EPS estimates ranging from $5.25 to $5.60. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that that provide coverage for Monsanto.

Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. The company had revenue of $4.23 billion for the quarter, compared to analysts’ expectations of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. Monsanto’s revenue was up 1.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.17 earnings per share.

A number of equities analysts recently commented on the stock. UBS AG downgraded shares of Monsanto from a “positive” rating to a “neutral” rating in a research note on Tuesday, June 27th. Royal Bank Of Canada reiterated a “hold” rating and set a $128.00 target price on shares of Monsanto in a research note on Wednesday, August 2nd. Piper Jaffray Companies set a $128.00 target price on shares of Monsanto and gave the stock a “buy” rating in a research note on Friday, August 11th. Jefferies Group LLC downgraded shares of Monsanto from a “buy” rating to a “hold” rating and set a $128.00 target price for the company. in a research note on Wednesday, July 12th. Finally, Barclays PLC boosted their target price on shares of Monsanto from $115.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Thursday, June 29th. One investment analyst has rated the stock with a sell rating, twelve have given a hold rating and eight have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $123.43.

Shares of Monsanto (NYSE MON) traded down 0.16% during mid-day trading on Monday, reaching $117.23. The company’s stock had a trading volume of 1,165,804 shares. The stock has a market cap of $51.50 billion, a P/E ratio of 25.32 and a beta of 1.07. The stock has a 50 day moving average of $117.21 and a 200-day moving average of $116.32. Monsanto has a one year low of $97.35 and a one year high of $118.97.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be issued a $0.54 dividend. The ex-dividend date is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.84%. Monsanto’s payout ratio is 46.75%.

In other news, SVP Janet M. Holloway sold 7,423 shares of the company’s stock in a transaction dated Tuesday, June 13th. The shares were sold at an average price of $118.00, for a total value of $875,914.00. Following the completion of the sale, the senior vice president now directly owns 33,645 shares of the company’s stock, valued at $3,970,110. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert T. Fraley sold 52,410 shares of the company’s stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $117.95, for a total transaction of $6,181,759.50. The disclosure for this sale can be found here. Insiders sold 71,133 shares of company stock valued at $8,397,515 over the last ninety days. Corporate insiders own 0.79% of the company’s stock.

Large investors have recently made changes to their positions in the company. Pinnacle Financial Partners Inc. purchased a new stake in shares of Monsanto in the second quarter valued at about $114,000. Bruderman Asset Management LLC purchased a new stake in shares of Monsanto in the second quarter valued at about $116,000. Acrospire Investment Management LLC purchased a new stake in shares of Monsanto in the first quarter valued at about $113,000. Tower Research Capital LLC TRC raised its holdings in shares of Monsanto by 230.1% in the second quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock valued at $128,000 after buying an additional 750 shares during the last quarter. Finally, Armbruster Capital Management Inc. raised its holdings in shares of Monsanto by 12.2% in the second quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock valued at $136,000 after buying an additional 125 shares during the last quarter. 74.79% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Brokerages Anticipate Monsanto Company (MON) Will Post Earnings of -$0.38 Per Share” was originally reported by Markets Daily and is owned by of Markets Daily. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://www.themarketsdaily.com/2017/09/11/brokerages-anticipate-monsanto-company-mon-will-post-earnings-of-0-38-per-share.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Get a free copy of the Zacks research report on Monsanto (MON)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply